Tam Anh General Hospital and Tam Anh Research Institute (TAMRI) are launching the VISTA-1 project to test the oral immunotherapy drug RBS2418, positioning Vietnam as a key participant in the global fight against terminal cancer.
The hospital has become the second medical facility under the Hanoi Department of Health (after Saint Paul General Hospital) to be named on the organ transplant map of Việt Nam.
